235980 — Medpacto Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual income statement for Medpacto, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	0	0	0	0
Cost of Revenue
Gross Profit	0	0	0	0	0
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	27,800	29,459	37,193	35,358	21,816
Operating Profit	-27,800	-29,459	-37,193	-35,358	-21,816
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-25,352	-17,040	-35,753	-35,325	-20,140
Provision for Income Taxes
Net Income After Taxes	-25,352	-17,040	-35,753	-35,325	-20,140
Net Income Before Extraordinary Items
Net Income	-25,352	-17,040	-35,753	-35,325	-20,140
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-25,352	-17,040	-35,753	-35,325	-20,140
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1,066	-710	-1,455	-1,354	-598
Dividends per Share